Scientists identify proteins that would predict the response to standard treatment in one of the most aggressive breast cancers
Through bioinformatics and in vitro studies, CONICET researchers identified two proteins that could predict whether standard treatment for a subtype of breast cancer, called HER2 positive, would be effective for people suffering from this disease. The study was published in the journal Cancers.
“The usual treatment for HER2-positive breast...